This book investigates the divergent institutional and economic pathways taken by Japan and the United States to commercialize recombinant DNA technology during the early stages of the biotechnology industry. Author Steven Collins utilizes a comparative framework to analyze how variations in financial, organizational, and regulatory resources shaped the industrial development of these two nations. By synthesizing economic history with science policy, the text proposes a model to explain why each country adopted specific strategies for technological innovation.

Experts recognize this work as a valuable contribution to the comparative study of industrial policy and technological innovation. Readers frequently note the academic density of the prose, which provides a rigorous examination of the structural differences between the Japanese and American biotech sectors.